RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AMG.F
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Thursday for Amgen Inc.
(Updated on Jul 04, 2024)

Sell candidate since Jul 03, 2024 Loss -0.05% PDF

The Amgen Inc. stock price fell by -0.0527% on the last day (Thursday, 4th Jul 2024) from 284.70€ to 284.55€. It has now fallen 7 days in a row. During the last trading day the stock fluctuated 2.50% from a day low at 284.55€ to a day high of 291.65€. The price has fallen in 7 of the last 10 days and is down by -0.58% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -24 shares and in total, 149 shares were bought and sold for approximately 42.40€ thousand.

Given the current short-term trend, the stock is expected to rise 16.95% during the next 3 months and, with a 90% probability hold a price between 332.77€ and 358.01€ at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AMG.F Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Amgen Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at 290.19€ and 285.18€. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, June 25, 2024, and so far it has fallen -5.53%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Amgen Inc. stock

Amgen Inc. finds support from accumulated volume at 281.35€ and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have controlled movements and therefore the general risk is considered low. However, be aware of low or falling volume and make sure to keep an eye on the stock. During the last day, the stock moved 7.10€ between high and low, or 2.50%. For the last week the stock has had daily average volatility of 1.99%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AMG.F) For The Upcoming Trading Day Of Friday 5th

For the upcoming trading day on Friday, 5th we expect Amgen Inc. to open at 286.92€, and during the day (based on 14 day Average True Range), to move between 278.94€ and 290.16€, which gives a possible trading interval of +/-5.61€ (+/-1.97%) up or down from last closing price. If Amgen Inc. takes out the full calculated possible swing range there will be an estimated 3.94% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at 287.30€ (0.97%) than the support at 281.35€ (1.12%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Amgen Inc. stock A Buy?

The Amgen Inc. stock holds several negative signals and despite the positive trend, we believe Amgen Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.441 Sell Candidate Unchanged

Predicted Opening Price for Amgen Inc. of Friday, July 5, 2024

Fair opening price July 5, 2024 Current price
286.92€ ( 0.83%) 284.55€

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AMG.F

Fibonacci Support & Resistance Levels

Level Price
R3 294.02 3.33%
R2 291.30 2.37%
R1 289.63 1.78%
Price 284.55
S1 284.20 -0.121%
S2 282.53 -0.710%
S3 279.82 -1.66%

Accumulated Volume Support & Resistance Levels

Level Price
R3 293.00 2.97%
R2 288.65 1.44%
R1 287.30 0.97%
Price 284.55
S1 281.35 -1.12%
S2 277.20 -2.58%
S3 256.10 -10.00%

AMG Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 May 16, 2024 May 16, 2024 Jun 07, 2024 2.06€ 0%
2 Feb 15, 2024 Feb 15, 2024 Feb 15, 2024 2.25€ 0%
3 Nov 16, 2023 Nov 16, 2023 Dec 08, 2023 2.13€ 0%
4 Aug 17, 2023 Aug 17, 2023 Aug 17, 2023 2.13€ 0%
5 May 17, 2023 May 17, 2023 May 17, 2023 2.13€ 0%

FAQ

What is the symbol for Amgen Inc. Stock and on which exchange is it traded?
The symbol for Amgen Inc. is AMG.F and it is traded on the FRA (Frankfurt Stock Exchange).

Should I buy or sell Amgen Inc. Stock?
The Amgen Inc. stock holds several negative signals and despite the positive trend, we believe Amgen Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Amgen Inc. Stock?
Amgen Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Amgen Inc. Stock.

What's the current price of Amgen Inc. Stock?
As of the end of day on the Jul 04, 2024, the price of an Amgen Inc. (AMG.F) share was 284.55€.

What is the 52-week high and low for Amgen Inc. Stock?
The 52-week high for Amgen Inc. Stock is 306.00€ and the 52-week low is 199.80€.

What is the market capitalization of Amgen Inc. Stock?
As of the Jul 04, 2024, the market capitalization of Amgen Inc. is 152.723B.

When is the next earnings date for Amgen Inc.?
The upcoming earnings date for Amgen Inc. is Aug 01, 2024.
Click to get the best stock tips daily for free!

About Amgen Inc.

Amgen. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopaus... AMG.F Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT